Skip to content

Effects of Shoe Longitudinal Bending Stiffness

Effects of Shoe Longitudinal Bending Stiffness on Changes in Energy Cost of Running During a 21 km Run

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04895501
Acronym
FAT-FLEX
Enrollment
21
Registered
2021-05-20
Start date
2022-02-07
Completion date
2022-06-28
Last updated
2022-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Runners

Keywords

NEUROMUSCULAR FATIGUE, ENERGETIC COST OF RUNNING, LONGITUDINAL BENDING STIFFNESS

Brief summary

Carbon plates inserted in competitive running shoes have been increasingly used in the past 2-3 years and several investigations have shown that these plates increase the longitudinal bending stiffness (LBS) of the shoe. It leads to a redistribution of muscle work and to a modification of the force generation conditions, which may reduce the energy cost of running (Cr) and improve performance.

Detailed description

Only one study has investigated the effects of LBS in running bouts longer than 8 minutes but on the biomechanics part, and their effects on neuromuscular fatigue and prolonged running performance. The aim of this study is to compare shoes with and without carbon plates during a prolonged (21 km) running exercise on Cr, plantar flexor neuromuscular fatigue and running kinetics and kinematics to estimate the changes high-LBS may induce on fatigue and subsequent performance.

Interventions

OTHERrunning flexible shoes

21kms of running flexible shoes followed by a time-to-exhaustion run.

Sponsors

Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* aged ≥ 18 and ≤ 50 years. * men * experienced, well-trained endurance runners with the capacity to run 21km in less than 1h 40 and who train more than 5h a week. * free from muscular, bone or joint injuries * free from neurologic disease * approval received from a physician

Exclusion criteria

* currently participating in a structured exercise program * injury in the 3 months prior to the protocol * chronic joint pathologies (e.g.: repetitive sprains, patellar or ligament problems) * the intake of corticosteroids within 3 months (inhalation, infiltration or history of prolonged corticosteroid therapy).

Design outcomes

Primary

MeasureTime frameDescription
energy cost of runningduring the last 4 minutes of a 21km raceamount of energy needed to travel a unit of distance

Secondary

MeasureTime frameDescription
ankle plantar flexorsduring the last 4 minutes of a 21km raceankle plantar flexors maximal voluntary contraction

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026